Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Harrison

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
European Journal of Preventive Cardiology|October 4, 2012
Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16Suneela Mehta, Sue Wells, Corina Grey, et al.
BJGP Open|November 11, 2020
Lipid levels and major adverse cardiovascular events in patients initiated on statins for primary prevention: an international population-based cohort study protocolJoseph E Blais, Ralph Kwame Akyea, Annelize Coetzee, et al.
Lancet (London, England)|May 9, 2018
Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation studyRomana Pylypchuk, Sue Wells, Andrew Kerr, et al.
Journal of Primary Health Care|June 1, 2011
Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15)Suneela Mehta, Sue Wells, Tania Riddell, et al.
Drug Delivery and Translational Research|March 28, 2018
Comparing human peritoneal fluid and phosphate-buffered saline for drug delivery: do we need bio-relevant media?Prabhat Bhusal, Jamie Lee Rahiri, Bruce Sua, et al.
International Journal of Epidemiology|December 22, 2015
Cohort Profile: The PREDICT Cardiovascular Disease Cohort in New Zealand Primary Care (PREDICT-CVD 19)Sue Wells, Tania Riddell, Andrew Kerr, et al.
Exploratory Research in Clinical and Social Pharmacy|June 30, 2025
Clinical utility of the Arabic medication-related burden quality of life (MRB-QoL) tool in hospital-based medicines optimisation services: A mixed methods feasibility studySundos Q Al-Ebrahim, Ahmad El Ouweini, Fatima Boura, et al.
The New Zealand Medical Journal|October 26, 2018
Feasibility and reliability of clinical coding surveillance for the routine monitoring of adverse drug events in New Zealand hospitalsJerome Ng, Penny Andrew, Paul Muir, et al.
BMJ Open Respiratory Research|May 22, 2024
DIGIPREDICT: physiological, behavioural and environmental predictors of asthma attacks-a prospective observational study using digital markers and artificial intelligence-study protocolAmy Hai Yan Chan, Braden Te Ao, Christina Baggott, et al.
Nature Medicine|April 8, 2024
Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother-child pairsAdrienne Y L Chan, Le Gao, Miyuki Hsing-Chun Hsieh, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
European Journal of Preventive Cardiology|October 4, 2012
Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16Suneela Mehta, Sue Wells, Corina Grey, et al.
BJGP Open|November 11, 2020
Lipid levels and major adverse cardiovascular events in patients initiated on statins for primary prevention: an international population-based cohort study protocolJoseph E Blais, Ralph Kwame Akyea, Annelize Coetzee, et al.
Lancet (London, England)|May 9, 2018
Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation studyRomana Pylypchuk, Sue Wells, Andrew Kerr, et al.
Journal of Primary Health Care|June 1, 2011
Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15)Suneela Mehta, Sue Wells, Tania Riddell, et al.
Drug Delivery and Translational Research|March 28, 2018
Comparing human peritoneal fluid and phosphate-buffered saline for drug delivery: do we need bio-relevant media?Prabhat Bhusal, Jamie Lee Rahiri, Bruce Sua, et al.
International Journal of Epidemiology|December 22, 2015
Cohort Profile: The PREDICT Cardiovascular Disease Cohort in New Zealand Primary Care (PREDICT-CVD 19)Sue Wells, Tania Riddell, Andrew Kerr, et al.
Exploratory Research in Clinical and Social Pharmacy|June 30, 2025
Clinical utility of the Arabic medication-related burden quality of life (MRB-QoL) tool in hospital-based medicines optimisation services: A mixed methods feasibility studySundos Q Al-Ebrahim, Ahmad El Ouweini, Fatima Boura, et al.
The New Zealand Medical Journal|October 26, 2018
Feasibility and reliability of clinical coding surveillance for the routine monitoring of adverse drug events in New Zealand hospitalsJerome Ng, Penny Andrew, Paul Muir, et al.
BMJ Open Respiratory Research|May 22, 2024
DIGIPREDICT: physiological, behavioural and environmental predictors of asthma attacks-a prospective observational study using digital markers and artificial intelligence-study protocolAmy Hai Yan Chan, Braden Te Ao, Christina Baggott, et al.
Nature Medicine|April 8, 2024
Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother-child pairsAdrienne Y L Chan, Le Gao, Miyuki Hsing-Chun Hsieh, et al.
Pageof 10